Fig. 2From: Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trialCYT107 Pharmacokinetics. Concentration of CYT107 was measured in patients’ plasma at 1, 3, 5, 7, 9 and 24 h after intravenous administration. Values reported are the pharmacokinetics results for each patient who received CYT 107 at day 1 in A n = 15 and at day 15 B n = 12Back to article page